Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 229-604-4 | CAS number: 6628-04-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From May 14 to August 3, 2015.
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Test method according to OECD Guideline 471 and GLP study.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5100 - Bacterial Reverse Mutation Test (August 1998)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- The Salmonella typhimurium histidine (his) reversion system measures his- to his+ reversions. The strains differentiate between base-pair (TA1535, TA100) and frameshift (TA1537, TA98) mutations.
The E.coli WP2 uvrA tryptophan (trp) reversion system measures trp- to trp+ reversions. It detects mutagens that cause base-pair substitutions (AT to GC). - Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Species / strain / cell type:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Metabolic activation system:
- Rat Liver Homogenate S9 Fraction
- Test concentrations with justification for top dose:
- Preliminary Concentration Range Finding test: 5000, 2500, 1000, 316, 100, 31.6 and 10 µg/plate.
Main tests: 5000, 2500, 1250, 625, 312.5, 156.25, 78.125 and 29.0625 µg/plate.
Complementary Confirmatory Mutation Test: 625; 312.5; 156.25; 78.125; 39.0625; 19.5313, 9.7656 and 4.8828 µg/plate. - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: Dimethyl sulfoxide (DMSO).
- Justification for choice of solvent/vehicle: Based on the available information and the results of a solubility test. - Positive controls:
- yes
- Remarks:
- without metabolic activation
- Positive control substance:
- other: 4-nitro-1,2-phenylenediamine (NPD) SIGMA-ALDRICH
- Remarks:
- TA98. 4 µg in DMSO.
- Positive controls:
- yes
- Remarks:
- without metabolic activation
- Positive control substance:
- sodium azide
- Remarks:
- TA100 and TA1535. 2 µg in Distilled water
- Positive controls:
- yes
- Remarks:
- without metabolic activation
- Positive control substance:
- 9-aminoacridine
- Remarks:
- TA1537. 50 µg in DMSO.
- Positive controls:
- yes
- Remarks:
- without metabolic activation
- Positive control substance:
- methylmethanesulfonate
- Remarks:
- E.coli WP2 uvrA. 2 µL in Distilled water.
- Positive controls:
- yes
- Remarks:
- with metabolic activation
- Positive control substance:
- other: 2-aminoanthracene (2AA)
- Remarks:
- Salmonella strains. 2 µg in DMSO.
- Positive controls:
- yes
- Remarks:
- with metabolic activation
- Positive control substance:
- other: 2-aminoanthracene (2AA)
- Remarks:
- E.coli WP2 uvrA. 50 µg in DMSO.
- Negative solvent / vehicle controls:
- yes
- Remarks:
- Dimethyl sulfoxide (DMSO)
- True negative controls:
- yes
- Remarks:
- Distilled water
- Details on test system and experimental conditions:
- METHOD OF APPLICATION:
Initial mutation test: Plate incorporation method.
Confirmatory mutation test: Plate incorporation/Preincubation method.
Complementary confirmatory mutation test: Preincubation method.
DURATION
- Preincubation period: Overnight.
- Exposure duration: 20 minutes
- Expression time (cells in growth medium): 48±1 hours.
NUMBER OF REPLICATIONS: Triplicate.
DETERMINATION OF CYTOTOXICITY
- Method: Reduced/slightly reduced background lawn. - Evaluation criteria:
- A test item was considered mutagenic if:
- a dose–related increase in the number of revertants occurred and/or;
- a reproducible biologically relevant positive response for at least one of the dose groups occurred in at least one strain with or without metabolic activation. - Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- positive
- Remarks:
- (at all concentrations)
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- (5000 μg/plate, without metabolic activation)
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with
- Genotoxicity:
- positive
- Remarks:
- (at all concentrations)
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- (5000, 2500 and 1250 μg/plate, without metabolic activation)
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- (1250 μg/plate, without metabolic activation)
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- (1250 μg/plate, without metabolic activation)
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- (Complementary confirmatory test: 625 μg/plate without metabolic activation).
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: No precipitate was detected in the Preliminary Range Finding Test.
Slight precipitate was detected on the plates in Initial Mutation Test in S.typhimurium TA1537 at 5000 μg/plate concentration with metabolic activation.
RANGE-FINDING/SCREENING STUDIES: It was observed a dose-related increase in the number of revertant colonies in S.typhimurium TA98 with metabolic activation. In S.typhimurium TA100 mutation factor values above the respective biological threshold value were also observed but the revertant counts were within the historical negative control range.
COMPARISON WITH HISTORICAL CONTROL DATA: The mean values of revertant colony numbers of untreated, negative (solvent) and positive control plates were within the historical control range in all strains.
ADDITIONAL INFORMATION ON CYTOTOXICITY: Inhibitory, cytotoxic effect was seen in the preliminary experiment in the both tester strains at 5000 μg/plate without metabolic activation.
In the Confirmatory Mutation Test using the pre-incubation method, excessive cytotoxicity was observed in the E.coli WP2 uvrA strain without metabolic activation at several concentrations. Therefore an additional experiment was performed in this strain.
Inhibitory, cytotoxicity was observed in the Confirmatory Mutation Test in S.typhimurium TA98 at 5000, 2500 and 1250 μg/plate, without metabolic activation, and in S.typhimurium TA100 and TA1535 at 1250 μg/plate without metabolic activation, and in S.typhimurium TA1537 at 5000 μg/plate without metabolic activation, and in E.coli WP2 uvrA at 625 μg/plate without metabolic activation. - Remarks on result:
- other: strain/cell type: TA1537
- Remarks:
- Migrated from field 'Test system'.
- Conclusions:
- Interpretation of results (migrated information):
ambiguous
The substance had mutagenic activity in the Salmonella typhimurium TA98 strain in the presence of metabolic activation and in Salmonella typhimuriumTA1537 strain in the presence and absence of metabolic activation system. However , no clear mutagenic activity was observed in the other three experimental strains. - Executive summary:
This study intended to evaluate the mutagenic potential of the test item. A Bacterial Reverse Mutation Assay was performed according to OECD Guideline 471 and following GLP.
The study included a Preliminary Compatibility Test, a Preliminary Concentration Range Finding Test (Informatory Toxicity Test), an Initial Mutation Test (Plate Incorporation Method), a Confirmatory Mutation Test (Plate Incorporation / Pre-Incubation Method) and a Complementary Confirmatory Mutation Test (Pre-Incubation Method).
In the Initial Mutation Test and Confirmatory Mutation Test, clear, reproducible positive effect was obtained in Salmonella typhimurium TA98 bacterial strain with metabolic activation and Salmonella typhimurium TA1537 bacterial strain with and without metabolic activation as the observed revertant colony numbers were above the respective biological threshold value and dose-related trends were also observed.
Inhibitory, cytotoxicity of the test item was observed in the Confirmatory Mutation Test and Complementary Confirmatory Mutation Test in Salmonella typhimurium TA98 bacterial strain at 5000, 2500 and 1250 μg/plate concentration without metabolic activation; and in Salmonella typhimurium TA100 and TA1535 strains at 5000, 2500 μg/plate concentration with and without metabolic activation; and in Salmonella typhimurium TA100 and TA1535 strains at 1250 μg/plate concentration without metabolic activation; and in Salmonella typhimurium TA1535 strains at 1250 μg/plate concentration with metabolic activation; and in Salmonella typhimurium TA1537 strains at 5000 μg/plate concentration without metabolic activation; and in Escherichia coli WP2 uvrA strain at 5000, 2500 μg/plate concentration with metabolic activation and in Escherichia coli WP2 uvrA strain at 625 μg/plate concentration without metabolic activation.
The substance had mutagenic activity in Salmonella typhimurium strains TA98 in the presence of metabolic activation system and in TA1537 strain in the presence and absence of metabolic activation system. However, no clear mutagenic activity was observed in the other three experimental strains.
Reference
Table 1. Summary table of the Confirmatory Mutation Test and Complementary Confirmatory Mutation test.
Concentrations (µg/plate) |
Mean values of revertants / Mutation factor (MF) |
Salmonella typhimurium |
Escherichia coli |
||||||||
TA98 |
TA100 |
TA1535 |
TA1537 |
WP2uvrA |
|||||||
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
||
Untreated control |
Mean |
16.0 |
19.0 |
117.0 |
113.7 |
8.0 |
9.7 |
5.0 |
3.3 |
47.7 |
54.3 |
MF |
0.83 |
0.85 |
1.06 |
0.98 |
0.96 |
1.00 |
0.83 |
0.42 |
0.99 |
1.10 |
|
DMSO control |
Mean |
19.3 |
22.3 |
110.3 |
116.0 |
8.3 |
9.7 |
6.0 |
8.0 |
48.3 |
49.3 |
MF |
1.00 |
1.00 |
1.00 |
1.00 |
1.00 |
1.00 |
1.00 |
1.00 |
1.00 |
1.00 |
|
Distilled water control |
Mean |
-- |
-- |
122.0 |
-- |
12.3 |
-- |
-- |
-- |
51.3 |
-- |
MF |
-- |
-- |
1.11 |
-- |
1.48 |
-- |
-- |
-- |
1.06 |
-- |
|
5000 |
Mean |
1.0 |
99.3 |
0.0 |
3.3 |
0.0 |
0.0 |
1941.3 |
806.7 |
-- |
8.0 |
MF |
0.05 |
4.45 |
0.00 |
0.03 |
0.00 |
0.00 |
323.56 |
100.83 |
-- |
0.16 |
|
2500 |
Mean |
2.3 |
141.0 |
3.0 |
129.0 |
0.7 |
4.3 |
261.0 |
131.0 |
-- |
14.7 |
MF |
0.12 |
6.31 |
0.03 |
1.11 |
0.08 |
0.45 |
43.5 |
16.38 |
-- |
0.30 |
|
1250 |
Mean |
7.7 |
123.0 |
32.3 |
219.3 |
4.3 |
9.3 |
21.7 |
23.7 |
-- |
56.3 |
MF |
0.40 |
5.51 |
0.29 |
1.89 |
0.52 |
0.97 |
3.61 |
2.96 |
-- |
1.14 |
|
625 |
Mean |
19.0 |
100.7 |
116.3 |
183.7 |
6.7 |
11.0 |
14.7 |
20.3 |
17.0 |
63.0 |
MF |
0.98 |
4.51 |
1.05 |
1.58 |
0.80 |
1.14 |
2.44 |
2.54 |
0.35 |
1.28 |
|
312.5 |
Mean |
13.0 |
86.3 |
108.3 |
162.3 |
8.3 |
12.7 |
6.7 |
8.7 |
52.3 |
55.7 |
MF |
0.67 |
3.87 |
0.98 |
1.40 |
1.00 |
1.31 |
1.11 |
1.08 |
1.08 |
1.13 |
|
156.25 |
Mean |
17.0 |
52.3 |
110.7 |
137.7 |
9.0 |
10.0 |
7.0 |
8.7 |
45.7 |
52.0 |
MF |
0.88 |
2.34 |
1.00 |
1.19 |
1.08 |
1.03 |
1.17 |
1.08 |
0.94 |
1.05 |
|
78.125 |
Mean |
18.0 |
40.0 |
117.7 |
116.7 |
8.3 |
12.0 |
7.0 |
9.0 |
48.0 |
50.3 |
MF |
0.93 |
1.79 |
1.07 |
1.01 |
1.00 |
1.24 |
1.17 |
1.13 |
0.99 |
1.02 |
|
29.0625 |
Mean |
16.7 |
35.3 |
128.7 |
111.7 |
9.0 |
10.3 |
8.0 |
8.0 |
51.0 |
48.0 |
MF |
0.86 |
1.58 |
1.17 |
0.96 |
1.08 |
1.07 |
1.33 |
1.00 |
1.06 |
0.97 |
|
19.5313 |
Mean |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
51.0 |
-- |
MF |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
1.06 |
-- |
|
9.7656 |
Mean |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
49.7 |
-- |
MF |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
1.03 |
-- |
|
4.8828 |
Mean |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
54.0 |
-- |
MF |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
1.12 |
-- |
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (positive)
Additional information
Key study: A Bacterial Reverse Mutation Assay was performed according to OECD Guideline 471 and following GLP.
In the Initial Mutation Test and Confirmatory Mutation Test, clear, reproducible positive effect was obtained in Salmonella typhimurium TA98 bacterial strain with metabolic activation and Salmonella typhimurium TA1537 bacterial strain with and without metabolic activation as the observed revertant colony numbers were above the respective biological threshold value and dose-related trends were also observed.
Inhibitory, cytotoxicity of the test item was observed in the Confirmatory Mutation Test and Complementary Confirmatory Mutation Test in Salmonella typhimurium TA98 bacterial strain at 5000, 2500 and 1250 μg/plate concentration without metabolic activation; and in Salmonella typhimurium TA100 and TA1535 strains at 5000, 2500 μg/plate concentration with and without metabolic activation; and in Salmonella typhimurium TA100 and TA1535 strains at 1250 μg/plate concentration without metabolic activation; and in Salmonella typhimurium TA1535 strains at 1250 μg/plate concentration with metabolic activation; and in Salmonella typhimurium TA1537 strains at 5000 μg/plate concentration without metabolic activation; and in Escherichia coli WP2 uvrA strain at 5000, 2500 μg/plate concentration with metabolic activation and in Escherichia coli WP2 uvrA strain at 625 μg/plate concentration without metabolic activation.
The substance had mutagenic activity inSalmonella typhimuriumstrains TA98 in the presence of metabolic activation system and in TA1537 strain in the presence and absence of metabolic activation system. However, no clear mutagenic activity was observed in the other three experimental strains.
Justification for selection of genetic toxicity endpoint
One study available.
Justification for classification or non-classification
Based on the available data, the substance is not classified for mutagenicity according to CLP Regulation (EC) no. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.